Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. EFFECT Other Notice of Effectiveness
  5. 424B3 Offering Prospectus
  6. S-1/A Offering Registration Statement
  7. S-1/A Offering Registration Statement
  8. CERTNAS Other Certification by the Nasdaq Stock Market
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. 8-A12B Other Registration of Securities
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. FWP Offering Free Writing Prospectus
  13. S-1/A Offering Registration Statement
  14. S-1/A Offering Registration Statement
  15. UPLOAD Other SEC-generated Letter
  16. S-1/A Offering Registration Statement
  17. UPLOAD Other SEC-generated Letter
  18. S-1/A Offering Registration Statement
  19. UPLOAD Other SEC-generated Letter
  20. S-1/A Offering Registration Statement

Page 30 of 31 · 604 filings